Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
82 studies found for:    Open Studies | "Lacrimal Apparatus Diseases"
Show Display Options
Rank Status Study
1 Unknown  Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease
Condition: Dry Eye Syndromes
Interventions: Drug: euphrasia based homeopathic therapy and cyclosporin;   Drug: cyclosporin solution
2 Unknown  Comparison of Efficacy, Safety and Anti-Inflammatory Effect Between Topical 0.05%Cyclosporine A Emulsion and REFRESH® in Patients With Moderate to Severe Dry Eyes
Condition: Dry Eye
Intervention: Drug: 0.05% cyclosporin eye drop
3 Not yet recruiting Changes in Tear Osmolarity Over Time With Sustained Use of TheraTears
Condition: Dry Eye Syndrome
Intervention: Other: TheraTears lubricating drops
4 Recruiting A Safety and Efficacy Study of OPTIVE FUSION™ With VISMED® Multi for the Management of Dry Eye
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Interventions: Drug: carboxymethylcellulose 0.5%/glycerin 0.9%;   Drug: sodium hyaluronate 0.18%
5 Recruiting Dry Eye Assessment and Management Study
Condition: Dry Eye
Interventions: Drug: Omega-3 supplements;   Drug: Placebo
6 Recruiting DNase Treatment for Dry Eyes
Condition: Dry Eye
Interventions: Drug: DNase;   Drug: Vehicle
7 Recruiting Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments
Conditions: Rheumatoid Arthritis;   Healthy Subjects;   Osteoarthritis;   Auto-immune Disease;   Lupus;   Systemic Sclerosis;   Sjögren Syndrome;   Spondylitis;   Crystal Rheumatisms
Intervention: Other: Comparison of Bregs levels
8 Recruiting The Research Registry for Neonatal Lupus
Conditions: Neonatal Lupus;   Systemic Lupus Erythematosus;   Sjogren's Syndrome;   Congenital Heart Block
Intervention: Other: No intervention; observational
9 Recruiting A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease
Condition: Dry Eye Syndromes
Interventions: Drug: Carboxymethylcellulose Sodium Based Eye Drop;   Drug: Carboxymethylcellulose Sodium 1.0%
10 Unknown  Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of Osmolarity
Condition: Dry Eye
Interventions: Drug: FreshKote;   Drug: Systane
11 Recruiting Efficacy and Safety Study of Haporine-S for Treatment of Moderate to Severe Dry Eye Syndromes
Condition: Dry Eye Syndromes
Interventions: Drug: Haporine-S;   Drug: Restasis (cyclosporine 0.05%)
12 Unknown  The Evaluation of Thiol Redox Status in Conjunctiva of Dry Eye Patients
Condition: Dry Eye Disease
Intervention:
13 Recruiting A Study of Flt3-Ligand Levels in Sjögrens Syndrome
Condition: Sjogrens Syndrome
Intervention:
14 Recruiting Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
Conditions: Keratoconjunctivitis Sicca;   Dry Eye Disease
Interventions: Drug: OTX-101 0.05%;   Drug: OTX-101 0.09%;   Drug: Vehicle
15 Not yet recruiting Topical Steroid Treatment For Dry Eye
Condition: Dry Eye
Intervention: Drug: Loteprednol Etabonate (FML)
16 Recruiting Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry Eye
Condition: Dry Eye
Interventions: Drug: PRO-148;   Drug: Systane
17 Recruiting Agricultural Health Study Follow-up
Conditions: Rheumatoid Arthritis;   Lupus Erythematosus, Systemic;   Sjogren's Syndrome
Intervention:
18 Unknown  Treatment of Dry Eye With Supplements
Condition: Dry Eye Syndromes
Intervention: Dietary Supplement: Vitamac® Tag and Nacht capsules
19 Recruiting Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease
Conditions: Primary Sjogren Syndrome;   Secondary Sjogren Syndrome;   Aqueous Deficient Dry Eye Disease;   Evaporative Dry Eye Disease
Interventions: Drug: Restasis;   Drug: Refresh Endura
20 Recruiting Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension Group
Condition: Dry Eye Syndromes
Intervention: Drug: Cyclosporine ophthalmic solution

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years